You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Kindstar has been granted exclusive rights to market the SLE-Key Rule-Out test in China, which will be the initial product offering stemming from the partnership.
The Medicare contractor proposed coverage for several cancer assays, but would not cover molecular respiratory virus assays or a test for inflammatory bowel disease.
In support of the launch, researchers published a study demonstrating the test can help improve diagnosis of patients with unclear results from standard cytology methods.
The company said that it can distinguish patients suffering from lupus from those with other autoimmune diseases using its antibody array platform.
Researchers from Germany and the US compared soluble TREM2 levels in people with autosomal dominant Alzheimer's disease and their unaffected siblings.